Suture Button vs Fibulink Fixation for Ankle Injury
Trial Summary
What is the purpose of this trial?
This project consists of a randomized controlled study design. Study candidates will include all patients 18 years or older, who were evaluated at UCSD and found to have an acute ankle syndesmosis injury requiring surgery. Patients who consent to study participation will be randomized to receive one of two standard of care procedures - either a suture button or Fibulink implant. Outcome measures, including the Olerud-Molander and American Orthopaedic Foot and Ankle Society scores, pain, range of motion, time to return to work, and radiographic evaluation will be collected for each participant. Given the potential degenerative changes and poor radiographic and clinical outcomes with inadequate repair of the syndesmosis, it is imperative to evaluate existing and emerging methods of fixation for patients with acute ankle fractures with syndesmosis injuries.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment Arthrex Tightrope for ankle injuries?
Research shows that the Arthrex Tightrope treatment for ankle injuries results in fewer implant-related problems and a lower need for implant removal compared to traditional screw fixation. It also allows for quicker return to weight-bearing and slightly better stability, making it a promising option for managing ankle syndesmosis injuries.12345
Is the suture button fixation method generally safe for humans?
The suture button fixation method, such as the Arthrex TightRope, is generally considered safe, but it can have complications like soft tissue irritation, infection, and wound issues. Some studies report fewer implant-related problems compared to traditional screw fixation, but there are risks of tendon entrapment and osteomyelitis (bone infection) in rare cases.12346
How is the TightRope treatment for ankle injuries different from other treatments?
The TightRope treatment for ankle injuries is unique because it allows for natural movement at the joint, supports early weight-bearing, and typically does not require a second surgery to remove the implant, unlike traditional screw fixation which restricts joint motion and often needs removal.12346
Eligibility Criteria
This trial is for adults over 18 with an acute ankle syndesmosis injury that needs surgery. Candidates must understand the consent form and can't be in another drug study, imprisoned, pregnant, have severe systemic disease not managed medically, or prefer a specific implant.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo surgical fixation with either a suture button or Fibulink implant for acute ankle syndesmosis injuries
Follow-up
Participants are monitored for safety and effectiveness, including pain, range of motion, and functional scores
Treatment Details
Interventions
- Arthrex Tightrope
- Synthes Fibulink
Arthrex Tightrope is already approved in United States for the following indications:
- Ankle syndesmosis injuries
- Ankle fractures with syndesmosis disruption
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor